PRICE T ROWE ASSOCIATES INC /MD/
Position in ALLO — Allogene Therapeutics, Inc.
CIK 80255
BALTIMORE, MD
Position in ALLO
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$9,649,708
-$3,479,692 QoQ
Shares Held
4,639,283
-13.8% QoQ
Ownership
1.34%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#20
of 209 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALLO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PRICE T ROWE ASSOCIATES INC /MD/ holds $17,929,584,838 across 304 Biotechnology names. ALLO ranks #121 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
2,678,047 | $2,484,611,664 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,529,709 | $953,834,749 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,728,421 | $858,558,562 | |
| 4 | KYMR |
Kymera Therapeutics, Inc.
|
7,112,980 | $815,645,416 | |
| 5 | RPRX |
Royalty Pharma plc
|
11,193,657 | $627,628,347 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
2,969,853 | $447,655,945 | |
| 7 | MRNA |
Moderna, Inc.
|
5,589,560 | $391,436,886 | |
| 8 | TWST |
Twist Bioscience Corp
|
3,634,652 | $373,932,997 |
All Filings in ALLO
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,649,708 | 4,639,283 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $13,129,400 | 5,380,902 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $4,396,706 | 3,209,275 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $4,560,067 | 3,677,474 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $4,554,885 | 4,030,872 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $6,140,765 | 4,206,004 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $9,554,267 | 4,485,572 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $13,548,479 | 4,838,743 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $13,491,962 | 5,790,542 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $18,673,956 | 4,177,619 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $7,612,424 | 2,371,472 | Shares | Sole | 2024-02-16 | |
| 2023-09-30 | $7,631,289 | 2,407,347 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $26,497,057 | 5,331,400 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $31,271,701 | 6,330,304 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $37,373,902 | 5,941,797 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $63,799,012 | 5,907,316 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $63,374,606 | 5,559,176 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $38,869,955 | 4,266,735 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $48,512,797 | 3,251,528 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $111,512,068 | 4,338,991 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $92,197,598 | 3,535,184 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $122,023,380 | 3,456,753 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $89,849,175 | 3,559,793 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $134,914,463 | 3,577,684 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $162,321,456 | 3,790,786 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $42,856,140 | 2,204,534 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||